Biogen ALS Drug Granted FDA Priority Review, Triggering Aduhelm Déjà Vu

 
• By Jessica Merrill
train track
Biogen's tofersen NDA follows a familiar track • Source: Shutterstock

More from Neurological

More from Therapeutic Category